KKR is debating on whether or not it should take part in a acquisition of CVS Health. The entry multiple is 7x 2021 EBITDA. CVS Health holds 4m In cash and cash equivalents and currently has $15m in long term debt. Financing fees for the transaction will be 5% of Enterprise Value. KKR will take out 3.5x EBITDA in senior notes and 2x EBITDA in one term loan. KKR requires a minimum cash balance of 3% of LTM revenue and currently holds 4m in cash. KKR's total revenue is 10m, its 2021 EBITDA was 7m and its existing cash is .5m. How much equity should KKR purchase to fund this transaction? Assume KKR will refinance CVS's debt